Clinical Trial

Nudging Preventive Screening Via Message Framing and Bundling

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is a randomized controlled field experiment embedded in the medical institution Early Diagnosis Program in Chile. Participants with two exams pending (a cancer screening test and a chronic disease test for diabetes and dyslipidemia) will be randomly assigned across a 3 × 3 factorial design: three message framing conditions (Basic, Risk/Importance, Peace of Mind) crossed with three exam-type conditions (cancer screening only, chronic disease test only, or both exams). Participants with only a cancer screening pending will be assigned to the 3 framing conditions and be encouraged to get the cancer screening. In both cases, participants are assigned to each experimental arm at twice the rate of an additional arm receiving the standard message currently used by the medical institution. This standard-message arm is included for operational purposes, is not part of the pre-specified analyses, and is thus not described in the "Arms and Intervention" section (or counted for "number of arms").
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-06-08; most recent amendment 2026-06-15.
Trial Details
NCT Number NCT07644910
Lead Sponsor University of Chile
Conditions Breast Neoplasms, Uterine Cervical Neoplasms, Colorectal Neoplasms, Prostatic Neoplasms, Diabetes Mellitus, Dyslipidemias
Enrollment 235,000 participants
Start Date 2026-06-08
Primary Completion 2026-09-08 (estimated)
Study Completion 2026-12-08 (estimated)
Updated on ClinicalTrials.gov 2026-06-17